Purdue researcher receives $1.38 million to fight against drug-resistant malaria in developing countries

A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries.

Cellares and Bristol Myers expand agreement for cell therapy

Bristol Myers Squibb will utilise the programme to assess the Cell Shuttle platform as an automated manufacturing process. Credit: Tada Images/Shutterstock.com. Cellares has entered an

October 12, 2023

Diets play a major role in reducing the risk of Alzheimer’s disease

In a detailed study, Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding published in the Journal of Alzheimer’s Disease, we can

December 5, 2023

AbbVie buys Third Rock’s Celsius for $250M to expand IBD pipeline

As AbbVie continues to tout its next generation of immunology drugs behind Humira, it’s buying an early-stage startup to boost its longer-term prospects in inflammatory

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.